期刊
NATURE REVIEWS CANCER
卷 13, 期 6, 页码 397-411出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3526
关键词
-
类别
资金
- US National Cancer Institute (NCI)
- US Department of Defense (DOD) [NCI-CA161978, DOD-PR111043, NCI-CA154754]
- US National Institutes of Health (NIH)
- NCI [NCI-CA21765, NIH-EY014867, NIH-EY018599, NCI-CA168875]
- American Lebanese Syrian Associated Charities
- Howard Hughes Medical Institute Early Career Scientist Award
Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous system. Over the past decade, our understanding of this disease has advanced tremendously. The future challenge is to apply the knowledge gained to developing risk-based therapies and, ultimately, improving outcome. In this Review we discuss the key discoveries in the developmental biology, molecular genetics and immunology of neuroblastoma, as well as new translational tools for bringing these promising scientific advances into the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据